Journal article icon

Journal article

Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein

Abstract:

Immunotherapy for metastatic melanoma offers great promise but, to date, only a subset of patients have responded. There is an urgent need to identify ways of allocating patients to the most beneficial therapy, to increase survival and decrease therapy-associated morbidity and costs. Blood-based biomarkers are of particular interest because of their straightforward implementation in routine clinical care. We sought to identify markers for dendritic cell (DC) vaccine-based immunotherapy agains...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.18632/oncotarget.18698

Authors


More by this author
Role:
Author
ORCID:
0000-0002-6862-9409
Expand authors...
Publisher:
Impact Journals Publisher's website
Journal:
Oncotarget Journal website
Volume:
8
Issue:
40
Pages:
67439-67456
Publication date:
2017-09-01
Acceptance date:
2017-05-22
DOI:
ISSN:
1949-2553
Pmid:
28978044
Source identifiers:
737177
Language:
English
Keywords:
Pubs id:
pubs:737177
UUID:
uuid:5a06503e-1a4a-4d26-836b-507496c3292b
Local pid:
pubs:737177
Deposit date:
2019-06-26

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP